Company Profile
Updated: 24-NOV-09Zymequest Inc.
Private Company, Headquarters Location
100 Cummings Ctr., Ste. 436H, Beverly, MA 01915-6122, United States
(978)232-8370, (978)232-8371 fax, http://www.zymequest.com
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Enzymatic blood conversion products.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Patent No.7,594,663 Issued on Sept. 29, Assigned to ZymeQuest for Rotating Seals(Massachusetts Inventor)
US Fed News Service, Including US State News; 10/5/2009; 359 words; ...systems. The inventors were issued U.S. Patent No. 7,594,663 on Sept. 29. The patent has been assigned to ZymeQuest Inc., Beverly, Mass. According to the abstract released by the U.S. Patent & Trademark Office: "The invention...
Examine the World Blood Banking & Blood Products Market.(Company overview)
Business Wire; 12/19/2008; 7184 words; ...Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and ZymeQuest, Inc. Leading Players discussed under the Plasma Fractionation segment include...
Start-ups looking hard for capital, but finding little
The Boston Globe; 11/10/2008; 863 words; ...Other companies giving presentations at the conference include EyeGate Pharmaceuticals Inc., of Waltham; IQuum Inc., of Marlborough; ZymeQuest Inc. in Beverly; Tomophase Corp., of Burlington; and Curative Biosciences Inc., of Waltham...
Massachusetts Inventors Develop Fluid Material Expressing Apparatus
US Fed News Service, Including US State News; 9/20/2008; 465 words; ...contamination." The inventors were issued U.S. Patent No. 7,425,192 on Sept. 16. The patent has been assigned to ZymeQuest Inc., Beverly, Mass. The original application was filed on Aug. 9, 2004, and is available at: http://patft...
A Report on the Worldwide Markets for Blood Banking & Blood Products: Including Area Breakdown, Forecasts to 2015 and 144 Company Profiles.
M2 Presswire; 7/8/2008; 925 words; ...Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and ZymeQuest, Inc. Market data and analytics are derived from primary and secondary research...
Recent News Articles
- ZymeQuest, Inc. Exercises Option for Worldwide Rights to Blood Platelet Modification Technology.
Business Wire - March 09, 2005 - ZymeQuest, Inc. Announces Three Key Appointments to Lead Research and Process Development of Blood Transfusion Technologies.
Business Wire - January 11, 2005 - ZymeQuest, Inc. Signs Process Development and Manufacturing Agreement with Cambrex Bio Science Baltimore.
Business Wire - December 07, 2004 - ZymeQuest, Inc. to Present at UBS Global Life Sciences Conference; Presentation to be Webcast Live at 3:30 p.m. ET Thursday, September 30.
Business Wire - September 23, 2004
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning